维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="Sissung"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Pharmacogenetics and regulation of human cytochrome P450 1B1:implications in hormone-mediated tumor metabolism and a novel target for therapeutic intervention显示文摘	Sissung TM Price DK Sparreboom A Figg WD	2006	Mol Cancer Res2006，4，3：	1
2	Expression of OATP family members in hormone - related cancers : potential markers of progression显示文摘	Pressler H Sissung TM Venzon D	2011	PLoS One2011，6，20：	1
3	Estrogen re- ceptor ct and aromatase polymorphisms affect risk, progno- sis, and therapeutic outcome in men with castration-resist- ant prostate cancer treated with docetaxel-based therapy 显示文摘	Sissung TM Danesi R Kirkland CT	2011	J Clin Endocrinol Metab2011，96，2：	1
4	CYP2D6 polymorphisms and the impact on tamoxifen therapy显示文摘	Sissung TM Sion AM Danesi R etal	2007	J Pharm Science2007，96，9：	1
5	ABCB1 genetic variation influences thetoxicity and clinical outcome of patients with androgen- independent prostate cancer treated with docetaxel 显示文摘	Sissung TM Baum CE Deeken J	2008	Clin Cancer Res2008，14，14：	1
6	Pharmacogenetics of Membrane Transporters: An Update on Current Approaches显示文摘	Tristan M. Sissung Caitlin E. Baum C. Tyler Kirkland Rui Gao Erin R. Gardner William D. Figg	2010	Molecular Biotechnology2010，，2：	1
7	The ERCCI N118N polymorphism does not change cellular ERCC1 protein expression or platinum sensitivity显示文摘	Gao R Reece K Sissung T		0，，1：	1
8	Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia 显示文摘	Sissung TM Mross K Steinberg SM	2006	Eur J Cancer2006，42，：	1
9	Current Status of Thalidomide and CC-5013 in the treatment of metastatic prostate cancer显示文摘	Sissung TM Thordardottir S Gardner ER	2009	Anti-Cancer Agent Me2009，9，10：	1
10	Pre-clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancer 显示文摘	Figg WD Li H Sissung T	2007	BJU Int2007，99，5：	1
11	Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia显示文摘	Sissung TM Mross K Steinberg SM	2006	Eur J Cancer2006，42，17：	1
12	Association of the CYP1B1 * 3 allele with survival in patients with prostate cancer receiving docetaxel 显示文摘	Sissung TM Danesi R Price KM	2008	Mol Cancer Ther2008，7，：	1
13	ABCB1 geneticvariation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel显示文摘	Sissung TM Baron CE Deeken J	2008	Clin Cancer Res2008，14，14：	1
14	Pharmacoge- netics of membrane transporters: an update on current approaches 显示文摘	SISSUNG TM BAUM CE KIRKLAND CT	2010	Mol Biotechnol2010，44，2：	1
15	Pharmacogenetics and regulation of human cytochrome P450 1B 1: implications in hormon- e-mediated tumor metabolism and a novel target for therapeutic intervention 显示文摘	Sissung TM Price DK Sparreboom A	2006	Mol Cancer Res2006，4，3：	1
16	Pre - clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in and rogen - independent prostate cancer显示文摘	Figg WD Li HQ Sissung T	2007	BJU Int2007，99，5：	1
17	Pharmacogenetics of membrane transporters: an update on current approaches 显示文摘	Sissung TM Baum CE Kirkland CT	2010	Mol Biotechnol2010，44，：	1
18	Current status of thalidomide and CC-5013 in the treatment of met- astatic prostate cancer显示文摘	Sissung TM Thordardottir S Gardner ER	2009	Anti-cancer Agents in Medicinal Chemistry2009，9，10：	1
19	Association of the CYP1 B1 * 3 allele with survival in patients with prostate eancer receiving docetaxel 显示文摘	Sissung TM Danesi R Price DK	2008	Mol Cancer Ther2008，7，1：	1
20	Pre-clinieat and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancer 显示文摘	FIGG W D LI H SISSUNG T	2007	BJU Int2007，99，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示